NACL Industries Limited has informed the exchanges about the quarter results
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 22 Jul 2026, 02:01 PM IST · BSE ID: 1e526848-5be1-4fc5-b44b-85a7378015f0
View Original BSE Filing (PDF)
💡
In Simple Terms
The company released its latest quarterly financial results and is selling its part-owned company, Nasense Labs, for ₹8.15 crore.
🤖 AI Summary
- NACL Industries Board approved Unaudited Standalone and Consolidated Financial Results for Q1 FY27.
- The Board approved the divestment of its entire equity stake in Nasense Labs Private Limited.
- Sale consideration for Nasense Labs Private Limited is ₹8,15,29,967 to Mr. Kanumuru Satyanarayana Raju.
- Nasense Labs contributed 10.93% of turnover and 18.12% of net worth in FY25.
- The transaction is expected to be completed within three months, subject to agreement terms.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Sale Consideration for Nasense Labs
₹8,15,29,967
Nasense Labs Turnover/Revenue/Income Contribution (FY25)
10.93%
Nasense Labs Net Worth Contribution (FY25)
18.12%
🏢 How This Affects the Company
The divestment of Nasense Labs Private Limited means it will cease to be an Associate Company, altering the group's business structure and focus. Nasense Labs contributed 10.93% to the company's turnover/revenue/income in FY25.
The company will receive ₹8,15,29,967 from the sale of Nasense Labs. This infusion of funds will impact the company's cash position. Nasense Labs represented 18.12% of the company's net worth as of March 31, 2025.
Operations will streamline as Nasense Labs will no longer be an associate company. This could lead to a reallocation of management focus and resources.
The transaction reduces the company's exposure to the specific business risks associated with Nasense Labs Private Limited. The buyer is not part of the promoter or promoter group, indicating an arm's length transaction.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this filing.
👤
Who Is Affected
All shareholders are affected as the company's asset base and future revenue streams will change with the divestment of an entity that contributed 10.93% of FY25 turnover.
🔍
Management Signal
Management is actively optimizing its asset portfolio by divesting an associate company to a third party, signaling a strategic focus and capital allocation decision.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Completion of Nasense Labs sale within the stated three-month timeline.
Announcement of subsequent quarterly results for full impact assessment.
Further details on utilization of the ₹8,15,29,967 sale proceeds.
LOW RISK
The divestment transaction details are clear, buyer is not a related party, and financial impact is defined.
💡 Investor Takeaway
The Board approved Q1 FY27 results and the divestment of Nasense Labs Private Limited for ₹8,15,29,967. Nasense Labs contributed 10.93% of turnover and 18.12% of net worth in FY25. The sale is expected within three months.
⚖️ Strengths & Concerns
✅ Positives
- Divestment brings in ₹8,15,29,967 in cash, enhancing financial liquidity for core operations or other strategic uses.
- The sale to a non-promoter group buyer at arm's length suggests a transparent and market-driven transaction for Nasense Labs.
⚠️ Concerns
- Nasense Labs contributed 10.93% of the company's turnover/revenue/income for FY25, indicating a notable reduction in group revenue contribution.
- Nasense Labs also accounted for 18.12% of the company's net worth as of March 31, 2025, which will be removed from the consolidated balance sheet post-divestment.
📅 Company Track Record
NACL Industries previously filed on April 27, 2026, about a Board meeting to approve FY26 audited results. On July 22, 2026, a prior filing also noted the divestment of Nasense Labs for ₹8,15,29,967 alongside Q1 FY27 results approval.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was the total sale consideration for NACL Industries' divestment of Nasense Labs Private Limited?
NACL Industries will receive an aggregate consideration of ₹8,15,29,967 for the sale of its entire equity stake in Nasense Labs Private Limited.
What percentage of NACL Industries' turnover did Nasense Labs contribute in FY25?
Nasense Labs Private Limited contributed 10.93% to NACL Industries' turnover/revenue/income during the last financial year ended March 31, 2025.
Who is the buyer of Nasense Labs Private Limited?
The proposed buyer of Nasense Labs Private Limited is Mr. Kanumuru Satyanarayana Raju, who is not part of the Promoter or Promoter Group of NACL Industries.
What was Nasense Labs Private Limited's contribution to NACL Industries' net worth in FY25?
Nasense Labs Private Limited contributed 18.12% to NACL Industries' net worth as of March 31, 2025.
Questions based on this BSE filing only. For information purposes.